Lexaria Bioscience Corp.
Nasdaq · Healthcare · Pharmaceutical Preparations · Kelowna, British Columbia, Canada
LEXX chart
What traders are saying about $LEXX
Latest postsLexaria Bioscience Corp. news
- Lexaria Bioscience Corp. Estimates – NASDAQ:LEXX
TradingView ·
- Lexaria Bioscience (LEXX) Completes Enrollment in Human Pilot St
GuruFocus ·
- Lexaria Bioscience Corp. (LEXX) Fully Enrolls GLP-1 Human Pilot Study #7
TradingView ·
- Lexaria's Human Study GLP-1-H26-7 Reaches Full Enrollment and Continues Dosing on Schedule
Yahoo Finance ·
- Lexaria tests its first oral tablet formula against Wegovy
Stock Titan ·
- LEXX Q4'26 Earnings: revenue estimate is 0 USD
TradingView ·
- Lexaria Announces Results from Animal Study GLP-1-A26-1
Yahoo Finance ·
- GLP-1 Weight-Loss/Diabetes Industries Continue Transition to Oral Medications
Yahoo Finance ·
- Lexaria Updates Financial Position
Yahoo Finance ·
- Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
Yahoo Finance ·
- Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
Yahoo Finance ·
- LEXX: Introducing DehydraTECH 3.0
Yahoo Finance ·
Lexaria Bioscience Corp. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $464,278 | $226,208 | $255,397 |
| Net income | -$11.9M | -$5.8M | -$6.7M | -$7.3M |
| Diluted EPS | $-0.66 | $-0.47 | $-1.01 | – |
| Total assets (year end) | $6.1M | $9.8M | $3.6M | $6.2M |
| Cash and equivalents (year end) | $4.3M | – | – | $4.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Lexaria Bioscience Corp.
- Ticker
- LEXX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Kelowna, British Columbia, Canada
- Incorporated in
- NV
- Fiscal year end
- August 31
- SEC CIK
- 1348362
- Former names
- Lexaria Corp., LEXARIA CORP.
Frequently asked questions
What exchange is Lexaria Bioscience Corp. listed on?
Lexaria Bioscience Corp. trades on the Nasdaq under the ticker symbol LEXX.
What industry is Lexaria Bioscience Corp. in?
Lexaria Bioscience Corp. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Lexaria Bioscience Corp. headquartered?
Lexaria Bioscience Corp.'s business address on file with the SEC is in Kelowna, British Columbia, Canada.
When does Lexaria Bioscience Corp.'s fiscal year end?
Lexaria Bioscience Corp.'s fiscal year ends on August 31.
How much revenue did Lexaria Bioscience Corp. report?
Lexaria Bioscience Corp. reported $464,278 in revenue for calendar year 2024, according to its SEC filings.